New research led by Anne Barton, Professor of Rheumatology at The University Manchester, will investigate the role bacteria plays in the development and treatment of psoriatic arthritis (PsA).
The NIHR/WT Manchester Clinical Research Facility (CRF) has recently launched the use of state-of-the-art gait analysis equipment within its Human Performance Laboratory.
The BRU has been awarded an MRC-NIHR National Phenome Centre pilot project, which will facilitate new and exciting research into identifying biomarkers that could predict RA patients' response to MTX.
Manchester Molecular Pathology Innovation Centre, to be led by Professor Tony Freemont, BRU Theme Lead , will employ and train scientists in the usof emerging molecular pathology research techniques.
The ICA Programme provides personal research training awards for healthcare professional who wish to develop careers that combine clinical research and leadership with continued clinical practice.
A study by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them.